Showing 901-910 of 1742 results for "".
New Guidelines for MS Treatment
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/new-guidelines-for-ms-treatment/30239/Will new guidelines address variability in the care of patients with MS?Direct Oral Anticoagulants for Secondary Stroke Prevention
https://practicalneurology.com/diseases-diagnoses/stroke/direct-oral-anticoagulants-for-secondary-stroke-prevention/30146/Optimal secondary stroke prevention includes reducing modifiable risk factors and providing anticoagulation for specific indications.Oculopharyngeal Muscular Dystrophy: Key Clinical Features, Genetic Diagnosis, and Management Strategies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/oculopharyngeal-muscular-dystrophy-key-clinical-features-genetic-diagnosis-and-management-strategies/56908/Early identification of oculopharyngeal muscular dystrophy can streamline diagnosis and help address dysphagia-related morbidity, a major driver of quality of life.Seizures and Epilepsy in the Elderly
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/seizures-and-epilepsy-in-the-elderly/30259/A focus on multidisciplinary care.A Choreographed Approach to the Treatment of Chorea
https://practicalneurology.com/diseases-diagnoses/movement-disorders/a-choreographed-approach-to-the-treatment-of-chorea/32166/The treatment approach to chorea benefits from individualized patient considerations and multidisciplinary methodology.The Best and Worst of Times?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-best-and-worst-of-times/30206/Despite exciting advances in diagnosis and myriad treatments, clinical management for patients with multiple sclerosis remains challenging.- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31487/Financial Strain of Neurological Illnesses: A Hidden Burden Leading to Medical BankruptcyA February 2005 study published in *Health Affairs* underscores the severe financial impact of medical expenses on Americans, revealing that approximately two million individuals face “medical bankruptcy” annual
Discontinuing Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapies-in-multiple-sclerosis/31875/Over the course of multiple sclerosis, there may come a point where the risks of disease-modifying therapies outweigh the benefits.Classic Hallucinogens in Neurology
https://practicalneurology.com/diseases-diagnoses/headache-pain/classic-hallucinogens-in-neurology/31953/Classic hallucinogens, among the fastest agents to cross the blood–brain barrier, have potential to treat neurologic conditions safely.Management Approaches in Radiographically Isolated Syndrome
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/management-approaches-in-radiographically-isolated-syndrome/32089/How best to define radiographically isolated syndrome has been the subject of debate; challenges in determining the best management approach remain.